ABT

Abbott Laboratories

115.51

USD

+6.11

+5.59%

Nov 04, 15:59 UTC -5

Closed

After-Market

115.16

-0.36

-0.31%

Abbott Laboratories (ABT) Earnings

ABT Earnings Reports

Positive Surprise Ratio

ABT beat 30 of 43 last estimates.

70%

Next Report

Date of Next Report

Jan 20, 2027

Estimate for Q4 26 (Revenue/ EPS)

$13.38B

$1.65

Implied change from Q3 26 (Revenue/ EPS)

+2.81%

+16.20%

Implied change from Q4 25 (Revenue/ EPS)

+16.75%

+10.00%

Abbott Laboratories earnings per share and revenue

On Oct 21, 2026, ABT reported earnings of 1.42 USD per share (EPS) for Q3 26, missing the estimate of 1.42 USD, resulting in a -0.68% surprise. Revenue reached 13.01 billion, compared to an expected 13.13 billion, with a -0.88% difference. The market reacted with a -1.89% price change (close before vs. close after earnings).

Looking ahead to Q4 26, -- analysts forecast an EPS of 1.65 USD, with revenue projected to reach 13.38 billion USD, implying an increase of 16.20% EPS, and increase of 2.81% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Medline Inc. Class A common stock

Report Date

Nov 04, 2026 For Q3 26

Estimate

$0.35

Actual

$0.44

Surprise

+23.91%

Zimmer Biomet Holdings, Inc.

Report Date

Nov 04, 2026 For Q3 26

Estimate

$1.90

Actual

$1.90

Surprise

-0.05%

Bio-Rad Laboratories, Inc.Class A

Report Date

Nov 04, 2026 For Q3 26

Estimate

$2.24

Actual

$2.65

Surprise

+17.92%

BillionToOne, Inc. Class A Common Stock

Report Date

Nov 04, 2026 For Q3 26

Estimate

$0.14

Actual

$0.32

Surprise

+115.34%

Envista Holdings Corporation Common stock, $0.01 par value per share

Report Date

Nov 04, 2026 For Q3 26

Estimate

$0.36

Actual

$0.40

Surprise

+10.04%

PERRIGO COMPANY PLC

Report Date

Nov 04, 2026 For Q3 26

Estimate

$0.50

Actual

$0.60

Surprise

+18.44%

Maravai LifeSciences Holdings, Inc. Class A Common Stock

Report Date

Nov 04, 2026 For Q3 26

Estimate

-$0.05

Actual

-$0.03

Surprise

+48.10%

LeMaitre Vascular, Inc.

Report Date

Nov 04, 2026 For Q3 26

Estimate

$0.70

Actual

$0.65

Surprise

-7.14%

Phibro Animal Health Corporation Class A

Report Date

Nov 04, 2026 For Q1 27

Estimate

$0.81

Actual

$0.79

Surprise

-2.58%

Evolus, Inc. Common Stock

Report Date

Nov 04, 2026 For Q3 26

Estimate

-$0.06

Actual

-$0.09

Surprise

-42.41%

FAQ

What were Abbott Laboratories's earnings and revenue for the latest quarter Q3 2026?

For Q3 2026, Abbott Laboratories reported EPS of $1.42, missing estimates by -0.68%, and revenue of $13.01B, -0.88% below expectations.

How did the market react to Abbott Laboratories's Q3 2026 earnings?

The stock price moved down -1.89%, changed from $102.45 before the earnings release to $100.51 the day after.

When is Abbott Laboratories expected to report next?

The next earning report is scheduled for Jan 20, 2027.

What are the forecasts for Abbott Laboratories's next earnings report?

Based on -- analysts, Abbott Laboratories is expected to report EPS of $1.65 and revenue of $13.38B for Q4 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.